> enlarge <

Letter of Excellence

Support in Product Development and Outlicensing

Dear Frau Pauly,

Galantos Pharma was established in 2005 in Mainz with the mission to develop innovative drug products for the treatment of degenerative brain diseases in the elderly.
ASPIRAS Project Consulting in Pharma and Biotech provided support in formulating development plans according to the international regulatory guidelines and provided templates for scientific reports as well as for the investigator’s brochure und a project profile. Thereby a sound data basis for the outlicensing of our development projects was built.
For development in the intended indication areas ASPIRAS provided in-depth knowledge about pharmacokinetic and pharmakodynamic issues, e. g. blood-brain-barrier-transport.
We were pleased with the professional attitude and the know-how of the ASPIRAS team in all areas of drug development which contributed and keeps contributing to safeguarding our future market success.


Yours sincerely

Prof. Dr. Alfred Maelicke